Save Entresto for Persistent Heart Failure Symptoms

You'll hear lots of buzz about Entresto (en-TRESS-toh), a new drug for systolic heart failure.

It's the first "angiotensin receptor neprilysin inhibitor" (ARNI)...and combines valsartan with sacubitril (sah-KYOO-bih-tril).

Sacubitril works by inhibiting the enzyme neprilysin. This increases sodium loss and vasodilation...and enhances ARB efficacy.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote